The University of Arkansas for Medical Sciences (UAMS) is launching a new entrepreneurship program designed to train individuals on how to shift health-science innovations to the marketplace.
The UAMS Translational Research Institute has announced its first four postdoctoral trainees in the Health Science Innovation & Entrepreneurship (HSIE) Postdoctoral Scholars Program.
The four participants in the program include:
- Samir Jenkins, Ph.D., nanomaterials and stem cell differentiation.
- Astha Malhotra, Ph.D., 3-D printing and tissue regeneration.
- Melody Penning, Ph.D., algorithms to predict adverse events in health care.
- Aaron Storey, Ph.D., identification of bacteria in synovial fluid.
Partnering with the Sam M. Walton College of Business at the University of Arkansas, the UAMS program will be a 15-week graduate training program that will incorporate distance education courses from the Walton College. The UAMS graduate students will work with MBA students to develop commercialization plans for the products/technologies they have designed.
“The concept of translational research challenges us to more quickly move biomedical innovations and new technologies into everyday practice, and knowledge of the commercialization process is a critical factor to meet that challenge,” said Nancy Rusch, Ph.D., the program’s co-director, and professor and chair of the Department of Pharmacology and Toxicology in the UAMS College of Medicine.
Dating back to 2016, the Walton College MBA program has had a connection with UAMS and developing health-science entrepreneurs. Carol Reeves, Ph.D., UA associate vice chancellor for entrepreneurship and innovation, led the instruction for the 2016 Entrepreneurship Boot Camp for UAMS students, alongside Rusch and Nancy Gray, Ph.D., the president of BioVentures.
“What the Translational Research Institute is doing with this program is a great complement to our MBA program and our graduate certificate in entrepreneurship. The UAMS scholars, biomedical discoveries and innovations are an exciting addition that strengthens both institutions,” Reeves says.
The project is supported by the Translational Research Institute, grant TL1 TR003109 funded by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.